baber/WOPTO huggingface dataset:
Patent ES-548300-A0 (ES)
IPC: C07D413/12
Filed: 1985-10-29
Abstract: Novel optical isomers and racemates of 4-hydroxy-3-quinoline-carboxylates of the formula    <IMAGE>  I wherein X is in the 5-, 6-, 7- or 8-position and is selected from the group consisting of hydrogen, halogen, alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 4 carbon atoms, -CF3, -SCF3 and -OCF3, R1 is selected from the group consisting of hydrogen and alkyl of 1 to 4 carbon atoms, R2 is selected from the group consisting of thiazolyl, 4,5-dihydrothiazolyl, pyridinyl, oxazolyl, isoxazolyl, imidazolyl, pyrimidyl and tetrazolyl all optionally substituted with alkyl of 1 to 4 carbon atoms and phenyl substituted with at least one member of the group consisting of -OH, alkyl and alkoxy of 1 to 4 carbon atoms, -CF3, -NO2 and halogen, R3 and R4 are individually selected from the group consisting of hydrogen, alkyl of 1 to 4 carbon atoms and aryl, R5 is selected from the group consisting of aryl of 6 to 14 carbon atoms, heteroaryl of 3 to 14 carbon atoms, alkyl of 1 to 14 carbon atoms, alkyl substituted with -NH2, -NHAlk or    <IMAGE>   alkenyl of 2 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms substituted with aryl of 6 to 14 carbon atoms, Alk and Alk' are alkyl of 1 to 6 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts with the proviso that when X is 8-CF3, R1 and R3 are hydrogen, R2 is 2-thiazolyl, R4 is methyl, R5 is not methyl having analgesic and anti-inflammatory activity.
Patent ES-554230-A0 (ES)
IPC: D03C1/14
Filed: 1986-04-22
Abstract: In a negative dobby for forming the warp shed in weaving looms, the stresses on some of the machine components are greatly reduced, whereby a more precise control of the heald frames is obtained, thanks to the fact that the controls transmitted to the crooks (9, 10), engaging the hooks (7, 8), by the means (12) reading the pattern of the fabric to be woven, are no longer affected by the strains deriving from the stresses imparted on said crooks (9, 10). This is obtained by operating the crooks (9, 10) by means of two-armed levers (13), controlled by the spiked roller (12)-forming the pattern reading means-and connected by spring means (17) to a square arm (18) of said crooks (9, 10), the rocking movements of said crooks (9, 10) and of said two-armed levers (13) being controlled by two distinct shafts (9A, 14).
Patent FI-821463-A0 (FI)
Inventor: SPINA NICOLA
IPC: C01F7/57
Filed: 1982-04-27
Abstract: An aluminium hydroxychloride having the general formula Aln(OH)mCl3n-m, wherein m is a number smaller than 3n and the ratio @@@@ is at least 2, preferably 5, for use as a size precipitant in paper making.
Patent FI-824453-A0 (FI)
Inventor: UMEHARA KAZUYOSHI
IPC: C07K5/06
Filed: 1982-12-27
Abstract: Compounds of the formula: 
<CHEM>
 wherein
 R<1> is hydrogen, alkanoyloxy or alkenoyloxy;
 R<2> is alkyl or alkenyl;
 R<3> and R<4> are each hydrogen, lower alkyl, hydroxy(lower)alkyl, ar(lower) alkyl, esterified carboxy(lower)alkyl, carboxy(lower)alkyl, protected amino(lower)alkyl or amino(lower)alkyl;
 R<5> is hydrogen, hydroxy(lower)alkyl, protected amino(lower)alkyl, amino(lower)alkyl, carboxy(lower)alkyl or esterified carboxy(lower)alkyl;
 R<6> is carboxy, esterifed carboxy or sulfo(lower)alkyl;
 A<1> , A<2> and A<3> are each bond or lower alkylene; and m and n are each an integer of 0 or 1; and their pharmaceutically-acceptable salts have anti-complementary activity and fibrinolytic activity, and are useful as therapeutic agents for immunecomplex diseases or autoimmune diseases such as nephritis, rheumatic diseases, systemic lupus erythematosus, etc. and thrombosis such as cerebral apoplexy, coronary insufficiency, pulmonary embolism.
Patent FI-831363-A0 (FI)
Inventor: SABELSTROEM JAN
IPC: B42C7/00
Filed: 1983-04-21
Abstract: An apparatus is provided for folding a sheet (1) into a folder provided with a spine and at least one cover. In the portion of the sheet forming the spine of the folder after folding, there is applied a bead (2) of binder for binding sheets of paper inserted in the ready folder, to the inside of the spine. The sheet is advanced with the bead parallel to the advancing direction via a rail (14) guiding the bead to folding and back-up means implemented as rollers (15, 16, 19, 20), for folding the cover side against the inside of the spine along a line situated closely adjacent and parallel to the bead.
Patent FI-852632-A0 (FI)
Inventor: KAHILA JOUKO
IPC: B01D33/21
Filed: 1985-07-03
Abstract: Method for transferring filtered pulp (6) from the filter surface (1) of a disc filter into the collection tube (7) and a disc filter for applying the method. The filtered pump (6) is drained off from the filter surface (1) onto a surface which rotates collectively with the filter disc. The said rotating surface pushes, while it is rotating, the pulp (6) off to the top end of the collection tube (7). The pulp detachment area on the filter surfaces (1) in the disc filter is situated above the pulp collection area which rotates collectively with the filter discs. <IMAGE>
Patent FI-863988-A0 (FI)
Inventor: NASHEF BASEM
IPC: A61M25/00
Filed: 1986-10-02
Abstract: A tubular device for the treatment of hollow organs is flexibly arranged and comprises a coating of silver. This coating is connected to a current source via connecting wires. Particularly, the tubular device is used for the treatment of the esophagus, and by the irritation caused by the electric current it is to effect an inflammation of the esophagus wall and thus a thickening of the latter so as to reduce the danger of hemorraghes of varicose veins within the esophagus or to prevent the hemorraghes. The tubular device is expansible in order to secure a close abutment of the silver coating against the mucous membrane of the esophagus.
Patent FI-875245-A0 (FI)
Inventor: GRUBER HARRY EDWARD
IPC: A61P37/00
Filed: 1987-11-27
Abstract: A method of treating disease by increasing the excretion of cellular adenosine including diseases of the immune, nervous and vascular systems involving administering to a patient stimulators of intracellular adenosine release.
Patent FI-891524-A0 (FI)
Inventor: ARNOLD LYLE JOHN
IPC: C12Q1/6832
Filed: 1989-03-30
Abstract: In an assay for a target nucleotide sequence employing hybridization with a target probe nucleotide sequence, cross reaction between the target probe and a non-target nucleotide sequence, capable of hybridizing with the target probe, is prevented or diminished by introducing, at some point during the hybridization, a non-target probe which hybridizes preferentially with the non-target nucleotide sequence. The melting temperature for the non-target probe/non-target nucleotide sequence hybrid is preferably greater than that of the target probe/non-target sequence hybrid. The hybridization can be carried out under isothermal conditions or preferentially with gradual cooling.
Patent FI-891729-A0 (FI)
Inventor: YAMASAKI KOMEI
IPC: G11B5/73
Filed: 1989-04-12
Abstract: A resin laminate comprising a layer of styrene-based polymer having mainly syndiotactic configuration and a thermoplastic resin layer, a metallized laminate comprising a layer of the styrene-based polymer described above and a metal layer, and process for producing these laminates are disclosed. In the laminated the styrene-based polymer layer and the thermoplastic resin layer may be biaxially stretched. The laminates are expected to be utilized for electrostatic capacitors, hot stamping foils, flexible printed circuit board substrates, food wrapping films, and other functional films including magnetic tapes, and ornament films.
Patent FI-896154-A0 (FI)
Inventor: MATHIVAT DENIS
IPC: C03B35/20
Filed: 1989-12-20
Abstract: The frame for supporting a sheet of glass heated above its softening point has a shape adapted to the outline of the glass sheet and mounted on a mobile carriage, and comprises a device for detecting the glass sheet, without contact, the size detected being converted into electrical pulses. 
<IMAGE>
Patent FI-900586-A0 (FI)
Inventor: SVENSSON LEIF RICKARD
IPC: B65D81/34
Filed: 1990-02-06
Abstract: This invention relates to a package for a cleaning mop or the like where the mop (12) is delivered packed in an hermetical cover (10). Said cover also comprises a receptacle (14) for a liquid the receptacle being breakable so that the liquid flows out into the cover and thereby impregnates the mop.
Patent FI-913198-A0 (FI)
Inventor: GIBOULT ALAIN
IPC: C03B37/05
Filed: 1991-07-01
Abstract: Method of forming mineral fibres, in which the material to be made into fibres spills in the molten state on the peripheral surface of the first of a series of centrifuging wheels rotating at high speed, to be made into fibres thereon by free centrifuging, the fibres formed by the different centrifuging wheels being picked up by gas streams emitted in the immediate proximity of the said wheels, in a direction essentially parallel to the axes of rotation of the wheels, at least one of these gas streams being emitted at a temperature of between 250 and 900 DEG C, preferably between 300 and 600 DEG C and also preferably around 500 DEG C. 
<IMAGE>
Patent FI-920329-A0 (FI)
Inventor: SUTTON RICHARD CALVIN
IPC: G01N33/545
Filed: 1992-01-24
Abstract: Biologically active reagents are prepared from particles of copolymers having highly active succinimide groups. The reagents are prepared by covalently attaching biologically active substances, for example antibodies, to the particles, directly or indirectly through amide groups by displacement of highly active succinimide groups on the particle surface. These reagents are used to advantage in analytical elements, methods for the detection of specific binding ligands (such as immunological species) and immunoassays, and in purification methods such as affinity chromatography.
Patent FI-923239-A0 (FI)
Inventor: BERNER SIBYLLE
IPC: C12Q1/6816
Filed: 1992-07-15
Abstract: A method for detecting nucleic acids in which a nucleic acid probe with two or more nucleotides which are modified by immobilisable groups and which are not directly adjacent in the nucleotide sequence is used. <IMAGE>
Patent FI-924397-A0 (FI)
Inventor: ELLINGBOE JOHN WATSON
IPC: C07D471/04
Filed: 1992-09-30
Abstract: This invention relates to pyrrolo-, pyrido-, azepino-, and azocinopyrimidines of the general formula I <CHEM> useful for treating hypertension or congestive heart failure and for preventing or treating restenosis following angioplasty, to pharmaceutical compositions, and to methods for production thereof.
Patent FI-944948-A0 (FI)
Inventor: MUELLER ANTON
IPC: A47C7/28
Filed: 1994-10-21
Abstract: The chair has a seat part (1) and a back part (2) which possess a seat and back area formed in each case by a wire grid, the wires of which are fastened by their ends (18, 26, 27), at least in some cases, to respective frames. To enable the chair to be manufactured simply and cost-effectively in such a way that damage to the clothing of the person sitting on the chair is prevented. The wire ends (18, 26, 27) are fastened to the mutually facing inner sides of frame parts (11, 6) of the frames. <IMAGE>
Patent FI-953133-A0 (FI)
Inventor: LJUSBERG HELENA
IPC: B01D61/14
Filed: 1995-06-22
Abstract: PCT No. PCT/SE93/01101 Sec. 371 Date Jun. 23, 1995 Sec. 102(e) Date Jun. 23, 1995 PCT Filed Dec. 22, 1993 PCT Pub. No. WO94/14982 PCT Pub. Date Jul. 7, 1994A process for manufacturing a high molecular weight molasses product having improved drying properties, which includes: feeding starting material molasses having a RT value of 8-45% and a color of at least 100,000 ICUMSA units to a membrane filtering plant (apparatus) having an inert membrane having a nominal cut off value of at least 2,000 dalton; and filtering a low molecular weight fraction as a permeate from a high molecular weight fraction as a retentate, and collecting the high molecular weight fraction having a color of at least two times the color of the starting molasses or at least 200,000 ICUMSA units.
Patent FI-955576-A0 (FI)
Inventor: SVENSSON ORVAR
IPC: B60R21/264
Filed: 1995-11-17
Abstract: The present invention relates to an arrangement for filling an empty, flexible container with a gas essentially instantaneously upon powerful retardation, wherein the gas-filled container functions as an injury-reducing, force-absorbing bag. The arrangement includes a high-pressure gas-filled pressure vessel, a conduit connecting the pressure vessel with the container, an opening device for opening the connection between the vessel and the container in the event of retardation forces that exceed a smallest value, and a retardation meter. The vessel comprises two pressure vessels (1, 2) each of which is closed by means of a closure means and each of which is connected to a respective connection conduit (3 and 4) which together lead to a common conduit (5) leading to the flexible container. The one pressure vessel (1) is filled with oxygen and an inert gas, and the other vessel (2) is filled with the inert gas and hydrogen, wherein the inert gas is helium, argon and/or nitrogen.
Patent FI-955579-A0 (FI)
Inventor: YARWOOD ANTHONY CHARLES
IPC: H04W4/90
Filed: 1995-11-20
Abstract: In a cellular radio system the facility is provided for a call to be broadcast from a control centre (Mx), (for example an emergency service controller), or from any of the mobile units (Ma), (Mb), (Mc) etc., to all of the others. Each cell allocates a single channel to the broadcast service, irrespective of the number of mobile units in the cell. This allows more efficient use of the available channels than the use of a separate channel for each mobile unit. In one embodiment no channel is allocated to a cell unless at least one mobile unit responds to a paging signal in that cell. Paging may continue throughout a broadcast call to allow a channel to be allocated when a mobile unit enters a previously unoccupied cell or to allow release of a channel should all mobiles leave a previously occupied cell. The broadcast facility can be provided on a cellular network which also supports other mobile units which do not receive the broadcast service, and whose operation is not affected by it.
Patent FI-971416-A0 (FI)
Inventor: NORDIN RUDOLF
IPC: A47L13/16
Filed: 1997-04-04
Abstract: PCT No. PCT/SE95/01035 Sec. 371 Date Mar. 24, 1997 Sec. 102(e) Date Mar. 24, 1997 PCT Filed Sep. 14, 1995 PCT Pub. No. WO96/10946 PCT Pub. Date Apr. 18, 1996The invention relates to a cleaning cloth for cleaning dirty surfaces comprising a base fabric having two sides with loops of yarn on each side. One side has longer loops of yarn having a normal fibre fineness and shorter loops of microfilament yarn for improved absorbency. The invention also relates to a mop having the cleaning cloth arranged thereon.
Patent AP-9701010-A0 (AP)
Title: Piperidineacetic acid derivatives useful as fibrinogen.
Inventor: ALLEN DAVID GEORGE
IPC: A61K31/445
Filed: 1995-12-21
Abstract: The invention provides the compounds of formula (i)and pharmaceutically acceptable derivatives thereof, in which: x represents either ch2-ch2 or ch=ch and y represnts a hydrigen atom or a phenylmethyl group, wherein the phenyl group is optionally substituted by one or more halogen atoms. Compounds of formula (i)inhibit blood platelet aggregation
Patent IL-61874-A0 (IL)
Title: 2,4-l-triiodoisophthalic acid derivatives,process for their preparation and x-ray contrast agents containing them
IPC: C07C233/92
Filed: 1981-01-07
Abstract: Ionic compounds of the formula   <IMAGE>   wherein X is -CONR1R2, -CH2NHxAcyl or -CH2OH; Y is -NR3R4, -NHxAcyl or OR5; R1, R2, R3 and R4 can be identical or different, and each is hydrogen, C1-6- alkyl or C2-8-alkyl substituted by 1-5 OH groups and/or by one C1-3-alkoxy group, R5 is C1-6 alkyl or C2-8-alkyl substituted by 1-5 OH groups and/or by one C1-3-alkoxy group, and Acyl, which can be the same or different in X and Y, is C2-6-alkanoyl or C2-6-alkanoyl substituted by 1-4 OH groups and/or by one C1-3-alkoxy group, or a physiologically compatible salt thereof with an inorganic or organic base, have valuable properties as X-ray contrast agents.
Patent IL-62841-A0 (IL)
Title: 1,4-dihydropyridine derivatives,their production and pharmaceutical compositions containing them
IPC: C07D405/04
Filed: 1981-05-11
Abstract: 1. Compound of the general formula I  see diagramm : EP0039863,P18,F1 in which R represents a phenyl radical which optionally contains 1 or 2 identical or different substituents from the group comprising nitro, chlorine, cyano or trifluoromethyl, with the exception of a phenyl radical which is at the same time ortho- and metadichlorosubstituted, when R**2 denotes methyl and R**4 denotes alkyl with 2-3 carbon atoms, R**1 represents a saturated hydrocarbon radical with up to 6 carbon atons which is optionally interrupted by an oxygen atom, R**2 and R**4 are always different and each represents hydrogen, alkyl with 1 to 4 carbon atoms or cyclohexylmethyl, with the exception of the compound diethyl-2-methyl-6-propyl-4-(3-nitrophenyl)-1,4- dihydropyridine-3,5-carboxylate.
Patent IL-70827-A0 (IL)
Title: Building blocks for construction models
IPC: A63H33/04
Filed: 1984-01-30
Abstract: A building block having side walls and a front face perpendicular to these is provided with two rows of coupling pins on one side of the front face and counter-coupling tubes on the other side for mechanically coupling two building blocks by means of a clamping action. In each row, each second coupling pin has an electrically conducting surface, while the coupling pins lying between these are electrically insulating. One row of conducting pins is displaced in the direction of the rows by one coupling pin from the adjacent row. On the other side of the front wall a contact bar is arranged which is connected electrically with the conducting coupling pins of an associated row. The bar has a contact area for producing electrical contact with a row of conducting coupling pins of an adjacent, coupled building block.
Patent IL-71098-A0 (IL)
Title: Substituted diazolylalkyl-carbinols,their preparation and antimycotic compositions containing them
IPC: C07D233/60
Filed: 1984-02-28
Abstract: 1. Substituted di- or triazolylalkyl-carbinols of the general formula   see diagramm : EP0120276,P20,F1   in which A represents a nitrogen atom or the CH group ; B represents a nitrogen atom or the CH group ; X represents hydrogen and straight-chain or branched alkyl with 1 to 6 carbon atoms ; Y represents straight-chain or branched alkyl with 1 to 6 carbon atoms ; and, if X represents hydrogen, also straight-chain or branched alkenyl and alkinyl with in each case 3 to 6 carbon atoms and benzyl which is optionally mono- to trisubstituted in the phenyl part by identical or different substituents, substituents which may mentioned being : halogen, alkyl with 1 to 4 carbon atoms, alkoxy and alkylthio with in each case 1 to 4 carbon atoms, halogenoalkyl, halogenoalkoxy and halogenoalkylthio with in each case 1 to 2 carbon and 1 to 5 identical or different halogen atoms, such as preferably fluorine and chlorine atoms, nitro and cyano ; R represents phenyl which is optionally mono- to tri-substituted by identical or different substituents, preferred substituents which may be mentioned being : halogen, alkyl with 1 to 4 carbon atoms, alkoxy and alkylthio with in each case 1 to 4 carbon atoms, halogenoalkyl, halogenoalkoxy and halogenoalkylthio with in each case 1 to 2 carbon and 1 to 5 identical or different halogen atoms, such as preferably fluorine and chlorine atoms, nitro, cyano, hydroxyl, hydroxycarbonyl with 1 to 4 carbon atoms in the alkyl part, hydroximinoalkyl with 1 to 4 carbon atoms, alkoximinoalkyl with 1 to 4 carbon atoms in each alkyl part, and phenyl, phenoxy, benzyl and benzyloxy, each of which is optionally substituted by halogen and/or alkyl with 1 to 2 carbon atoms ; R furthermore preferably represents the grouping   see diagramm : EP0120276,P20,F2   wherein Alk**1 represents straight-chain or branched alkyl with 1 to 4 carbon atoms ; Alk**2 represents straight-chain or branched alkyl with 1 to 4 carbon atoms ; Alk**1 and Alk**2, together with the carbon atom to which they are bonded, represent a 3- to 7-centered cycloaliphatic ring ; and R**1 represents, straight-chain or branched alkyl with 1 to 6 carbon atoms, alkenyl with 2 to 4 carbon atoms and phenyl, phenylalkyl with 1 to 4 carbon atoms in the alkyl part, phenoxy, phenylthio, phenoxyalkyl with 1 to 4 carbon atoms in the alkyl part, phenylthioalkyl with 1 to 4 carbon atoms in the alkyl part, benzyloxy and benzylthio, each of which is optionally mono- to trisubstituted in the phenyl part by identical or different substituents, preferred possible substituents being the phenyl substituents alreadly mentioned for R.
Patent IL-75239-A0 (IL)
Title: Beta-lactam antibiotics,their preparation,pharmaceutical compositions containing them and their use as growth-promoters in livestock rearing or as antioxidants
IPC: C07D417/12
Filed: 1985-05-20
Abstract: Novel  beta -lactam antibiotics of the formula   <IMAGE>   in which R1, R2 and R3, which may be identical or different, denote a substituted or unsubstituted alkyl radical or a monocyclic or bicyclic, optionally substituted, carbocyclic or heterocyclic ring, or R1 represents an optionally substituted alkyl radical or a monocyclic or bicyclic, substituted or unsubstituted, carbocyclic or heterocyclic ring, and R2 and R3, together with the N(+) atom, form an optionally substituted monocyclic or polycyclic ring which can be saturated or unsaturated and can contain oxygen, sulphur and nitrogen as other hetero atoms, or R1, R2 and R3, together with the N(+) atom, form a bridged, optionally substituted polycyclic ring which can be saturated or unsaturated and can contain oxygen, sulphur and nitrogen as other hetero atoms, and R4 represents hydrogen or optionally substituted alkyl, aryl or heterocyclyl or hydroxycarbonyl, lower alkoxycarbonyl, halogen, pseudohalogen or a group of the formula <IMAGE>   in which n denotes 0, 1 or 2, and B represents a direct bond, oxygen or a group   <IMAGE>  and A and W, independently of one another, represent hydrogen or optionally substituted alkyl, aryl or heterocyclyl, or together form an optionally substituted carbocyclic or heterocyclic ring.
Patent IL-76175-A0 (IL)
Title: Tricyclic oxindole derivatives and pharmaceutical compositions containing them
IPC: A61K31/40
Filed: 1985-08-23
Abstract: Tricyclic oxindole antiinflammatory agents of the formula: HET-CONH-Ar (I) and their pharmaceutically acceptable base salts, wherein HET is:where R<sub>1</sub> is C<sub>1</sub>-C<sub>3</sub> alkyl or phenyl; R<sub>3</sub> and R<sub>4</sub> are each H or CH<sub>3</sub>; X is N, CH or C(CH<sub>3</sub>); Y is 0 or S; Z is 0 or CG<sub>2</sub>; n is 1 or 2, and Ar is a specified optionally substituted phenyl or heterocyclic group.
Patent IL-87661-A0 (IL)
Title: New yeast strains providing for an enhanced rate of the fermentation of sugars,their production and their use
IPC: C12P7/06
Filed: 1988-09-02
Abstract: New yeast strains providing for an enhanced rate of the fermentation of sugars, and a process to obtain such yeasts and the use of these yeasts. Yeasts capable of improved fermentation of sugars, a process to obtain these yeasts and the use of these yeasts are provided. The yeasts show higher rates of metabolism resulting in for example higher carbon dioxide and ethanol production in media containing sugars, such as maltose, as main carbon and energy source. The fermentation rate of sugars is improved by the introduction into a yeast of one or more DNA constructs comprising at least one gene encoding a protein promoting the uptake and/or initial metabolic conversion of a transported sugar substrate.